Neurovascular Company Perfuze Raises €22.5M ($25M) Series A For New Stroke Treatment.
Galway, Ireland, February 7th, 2022. Perfuze, a medical device company developing next-generation catheter-based aspiration technology to treat large vessel occlusion acute ischemic stroke, has closed a €22.5 million Series A investment round. Proceeds from the financing will be used to drive the next stage of US clinical study and regulatory clearance of its Millipede System. […]
Neurovascular Company Perfuze Raises €22.5M ($25M) Series A For New Stroke Treatment. Read More »